| P2093 | author name string | Ekram Alias | |
| | Anak A. S. S. K. Dharmapatni | |
| | David R. Haynes | |
| | Tania N. Crotti | |
| P2860 | cites work | Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase | Q82991564 |
| | The 'disconnect' between synovitis and erosion in rheumatoid arthritis: a result of treatment or intrinsic to the disease process itself? | Q83202111 |
| | Pre-existing periodontitis exacerbates experimental arthritis in a mouse model | Q83703488 |
| | Polyethylene particles stimulate expression of ITAM-related molecules in peri-implant tissues and when stimulating osteoclastogenesis in vitro | Q84066411 |
| | Uncoupling of disease activity and structural damage. Does it matter clinically? | Q85505287 |
| | Levels of soluble osteoclast-associated receptor (sOSCAR) in rheumatoid arthritis: link to disease severity and cardiovascular risk | Q87138862 |
| | Bone erosions in rheumatoid arthritis: ultrasound findings in the early stage of the disease | Q87241743 |
| | Defining the value of structural inhibition. Is low-dose etanercept inferior to the standard dose? | Q87398891 |
| | Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization | Q72789070 |
| | Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint | Q72824611 |
| | Activated T lymphocytes support osteoclast formation in vitro | Q73149439 |
| | Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis | Q73490940 |
| | Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients | Q73880310 |
| | Particulate wear debris activates protein tyrosine kinases and nuclear factor kappaB, which down-regulates type I collagen synthesis in human osteoblasts | Q74285747 |
| | Association of clinical, radiological and synovial immunopathological responses to anti-rheumatic treatment in rheumatoid arthritis | Q77174764 |
| | The role of T cells in polyethylene particulate induced inflammation | Q77228028 |
| | Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin | Q79273226 |
| | Influence of rheumatoid arthritis on work participation in Australia | Q80463599 |
| | Phenotypic characteristics of T lymphocytes in the interfacial tissue of aseptically loosened prosthetic joints | Q80528516 |
| | Changes in serum levels of soluble osteoclast-associated receptor in human rheumatoid arthritis | Q82273354 |
| | RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis | Q82615147 |
| | Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1 | Q24300916 |
| | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype | Q24611595 |
| | DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features | Q24672682 |
| | Impaired differentiation of osteoclasts in TREM-2-deficient individuals | Q24672735 |
| | A novel member of the leukocyte receptor complex regulates osteoclast differentiation | Q24675157 |
| | The role of osteoimmunology in periodontal disease | Q26822821 |
| | Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice | Q28207641 |
| | Association of the OSCAR promoter polymorphism with BMD in postmenopausal women | Q28260856 |
| | OSCAR is an FcRgamma-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells | Q28262732 |
| | Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis | Q28267970 |
| | Ligation of the FcR gamma chain-associated human osteoclast-associated receptor enhances the proinflammatory responses of human monocytes and neutrophils | Q28298606 |
| | Fc receptor gamma-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responses | Q28302398 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 |
| | Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 |
| | Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. | Q33908939 |
| | Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease | Q33999537 |
| | Effective in vitro clearance of Porphyromonas gingivalis by Fc alpha receptor I (CD89) on gingival crevicular neutrophils | Q34007186 |
| | Autoamplification of NFATc1 expression determines its essential role in bone homeostasis | Q42972503 |
| | Tissue response in relation to type of wear particles around failed hip arthroplasties | Q43460460 |
| | NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription | Q44159701 |
| | RANKL regulates endothelial cell survival through the phosphatidylinositol 3′‐kinase/Akt signal transduction pathway | Q44590687 |
| | Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis | Q46275403 |
| | Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva | Q46357914 |
| | Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis | Q46620740 |
| | Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis | Q46917608 |
| | Prevalence of periodontitis in adults in the United States: 2009 and 2010. | Q47203547 |
| | Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR). | Q47377722 |
| | Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis | Q47761859 |
| | RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis | Q47884508 |
| | Nasu-Hakola disease with a splicing mutation of TREM2 in a Japanese family. | Q48953001 |
| | Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome. | Q51118502 |
| | Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis. | Q51151290 |
| | The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants. | Q51171484 |
| | [The significance of wear and material fatigue in loosening of hip prostheses] | Q52487012 |
| | The osteoclast-associated receptor (OSCAR) is a novel receptor regulated by oxidized low-density lipoprotein in human endothelial cells. | Q53212010 |
| | Over-expression of p53/BAK in aseptic loosening after total hip replacement. | Q53638592 |
| | Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. | Q53660636 |
| | Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. | Q53945794 |
| | Gene expression of transcription factor NFATc1 in periodontal diseases. | Q54389893 |
| | Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis. | Q54514161 |
| | 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 |
| | Cytokines and osteolysis around total hip prostheses | Q57009251 |
| | Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells | Q57184743 |
| | Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues | Q60038324 |
| | The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis | Q67295783 |
| | Osteolysis in alloarthroplasty of the hip. The role of bone cement fragmentation | Q68538262 |
| | The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis | Q71614193 |
| | Osteolysis around uncemented acetabular components of cobalt-chrome surface replacement hip arthroplasty | Q72269973 |
| | The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis | Q34346237 |
| | The role of osteoclast differentiation in aseptic loosening | Q34538684 |
| | NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation | Q34565548 |
| | Review of osteoimmunology and the host response in endodontic and periodontal lesions | Q34920792 |
| | OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice | Q35187075 |
| | B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease | Q35222008 |
| | Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis | Q35551233 |
| | Osteoimmunology: interactions of the immune and skeletal systems | Q35727803 |
| | Regulation of osteoclast activity in peri-implant tissues | Q35756689 |
| | Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis | Q35764588 |
| | TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis | Q35788463 |
| | Cellular response to prosthetic wear debris differs in patients with and without rheumatoid arthritis | Q35798932 |
| | Mechanistic insight into osteoclast differentiation in osteoimmunology | Q36073894 |
| | Periodontitis and rheumatoid arthritis: a review. | Q36309246 |
| | Role of ITAM-containing adapter proteins and their receptors in the immune system and bone | Q36324920 |
| | Osteoclasts, rheumatoid arthritis, and osteoimmunology | Q36501073 |
| | The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints | Q36907683 |
| | TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis | Q37066493 |
| | Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia | Q37363311 |
| | A potential role of myeloid DAP12-associating lectin (MDL)-1 in the regulation of inflammation in rheumatoid arthritis patients | Q37500085 |
| | Osteoimmunology: crosstalk between the immune and bone systems | Q37544448 |
| | The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase | Q37647341 |
| | The role of osteoclast-associated receptor in osteoimmunology. | Q37822578 |
| | Forget personalised medicine and focus on abating disease activity | Q38058492 |
| | Bone remodelling in inflammatory arthritis | Q38068695 |
| | Osteoimmunology in orthodontic tooth movement. | Q38231572 |
| | Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos | Q38342636 |
| | Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator | Q38363724 |
| | Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis | Q39573849 |
| | Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis | Q39653219 |
| | The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles | Q39863734 |
| | Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. | Q39936079 |
| | PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter. | Q40010762 |
| | The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells | Q40599606 |
| | The host response to the microbial challenge in periodontitis: assembling the players | Q41754952 |
| | Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patients | Q42115715 |
| | Periodontitis in RA-the citrullinated enolase connection. | Q42916208 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| | tissue | Q40397 |
| | human musculoskeletal system | Q726543 |
| | signal transduction | Q828130 |
| | osteolysis | Q2035084 |
| | metabolic bone disease | Q6822340 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 281287 | |
| P577 | publication date | 2015-01-01 | |
| | 2015-05-03 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss | |
| P478 | volume | 2015 | |